| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 78,819 | 71,222 | 46,077 | 96,271 | | Cost of Revenue | 34,688 | 29,595 | 17,660 | 36,223 | | | Gross Profit | 44,131 | 41,627 | 28,417 | 60,048 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,359 | 21,492 | 15,345 | 34,592 | | Non Recurring |
-
|
-
|
-
| 12,255 | | Others | 1,409 | 1,850 | 1,859 | 1,371 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,363 | 18,285 | 11,213 | 11,829 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (49) | (16) | (99) | 199 | | Earnings Before Interest And Taxes | 13,750 | 18,095 | 11,553 | 11,459 | | Interest Expense | 1,107 | 1,620 | 1,579 | 1,414 | | Income Before Tax | 12,644 | 16,475 | 9,973 | 10,045 | | Income Tax Expense | 3,991 | 3,369 | 2,103 | 2,003 | | Minority Interest | 119 |
-
|
-
| (28) | | | | Net Income From Continuing Ops | 8,473 | 13,106 | 7,870 | 8,041 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,772 | 13,106 | 7,870 | 8,041 | | Preferred Stock And Other Adjustments | (120) | 123 | (4) |
-
| | | Net Income Applicable To Common Shares | $8,652 | $13,229 | $7,867 | $8,041 |
|
0.51% Nasdaq 
Income Statement
